YZR Capital

Fosun RZ Capital was founded in 2013. As a leading industry investment institution with a global layout and unique resources, Fosun RZ Capital focuses on investment in deep tech, AI, fin-tech, healthcare, e-commerce, logistics and travel industries. It is built to empower the globalization of innovative start-ups with its indispensable industry resources in the four major business sectors of Fosun including health, happiness, wealth and smart manufacturing. Fosun RZ Capital is always empowering and evolving together with companies globally. Fosun RZ Capital is committed to becoming an essential investor of global business leaders in the era of technology business innovation. Fosun RZ Capital covers cutting-edge technological innovation in the United States and Israel and high-growth emerging markets in China, India, and Southeast Asia, creating an influential global industry-wide innovation ecosystem. It has a long-term focus on investment in high-growth, high-tech companies in significant economic growth regions worldwide.

WENVEST Capital is a private investment firm and emerged to become an entrepreneurial minded Venture Capital investor for Growth. The team of WENVEST Capital is dedicated to support the digital leaders of tomorrow with capital, know-how and network. We are based in Munich and are looking for investment opportunities primarily in the GAS region. STRATEGY & INVESTMENT CRITERIA We are entrepreneurial minded investors and partners, investing into pre-growth and growth companies, typically around Seed phase. With our first investment into a company, we usually invest in the range of EUR 0.25m to EUR 1.0m and reserve further capital for future financing rounds (we are flexible to join an existing consortium or lead a financing round). From joining your board, to supporting in future fundraising, strategic & operational sparring or hiring, we can be your partner of choice. Note: Our initial check size does not correlate with investment phase and is excluding of any follow-on commitments. Areas of Investment in B2B Technology Digital Transformation Next generation of Financial Instituions & Governance Business process optimization & increased productivity Cloud based solutions around Data & AI Digital Health Digital health solutions & healthcare system revolution FoodTech & healthy living Climate Solutions Enabler for CO2 reduction across industries Waste reduction & alternative resources Solutions towards reporting, monitoring and offsetting Further Investment Criteria First Revenues and Proof of Concept Significant USP and Defensible Technology Excellent Founder and Management Team Scalability Potential

InVitro Capital is a venture studio that creates, builds, and exits companies in the AI and B2B space. With a primary focus on Healthcare and SaaS, Invitro has developed a unique recipe to de-risk startup innovation and help aspiring exceptional entrepreneurs identify and capitalize on promising opportunities. At InVitro, we believe that the best startups are built by teams with deep domain expertise and a passion for solving real-world problems. That's why we invest in and partner with entrepreneurs who have a proven track record of success and a vision for the future. We provide our portfolio companies with the operational muscles and support they need to succeed, including: Seed funding. Access to our network of mentors and advisors. Expertise in tech, marketing, sales, and business development. Help with go-to-market strategy. We also have a unique approach to exits. Instead of waiting for a large tech company to come knocking, we actively work with our portfolio companies to develop and execute their own exit strategies. This allows us to maximize returns for our investors and give our entrepreneurs the freedom to pursue their next big idea

Our expertise in biopharma and biotech investments. With decades of experience and a robust network within the biopharma and biotech industries, our team offers unparalleled insight into the scientific and financial landscapes. We are dedicated to identifying transformative therapies and supporting companies that are pioneering the future of healthcare. Empowering entrepeneurs to build leading companies Biovance Capital works closely with entrepreneurs to build leading companies with transformative treatments for patients in need. Stage: We invest in early-stage companies at seed and Series A rounds across Europe, with a focus in Southern countries. Technology: We invest in biotech companies developing therapeutics in any modality and therapeutic area. We require robust and appropriate preclinical models and patented or patentable assets before investing. Market: Large target market with a clear regulatory pathway for approval, with favorable reimbursement and pricing policies. Exit Potential: Sectors with VC/M&A or IPO activity, featuring profitable exits and multiple potential acquirers. Sustainability: During the due diligence process, sustainability risks are taken into account, and whenever identified, mitigation measures are proposed.

Our mission is to establish a partnership with companies worldwide and boost Taiwan’s economic growth. Taiwania Capital is a venture capital that focuses on investing in technologies and biotech areas start-ups that are Taiwan or US-based with disruptive and advanced technology. Taiwania Capital is named after Taiwania cryptomerioides, a unique tree species that took its name from Taiwan in 1906. With heights reaching up to 90 meters, the Taiwania tree is one of the tallest tree species in Asia, and surrounding it is a diverse and vibrant ecosystem. By linking technology and capital, Taiwania Capital aspires to also create a robust ecosystem in Taiwan that is rooted in entrepreneurial innovation.